Market closedADR

Immunocore/$IMCR

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About Immunocore

Immunocore Holdings PLC is a late-stage biotechnology company engaged in the development of a novel class of TCR bispecific immunotherapies for the treatment of cancer, infectious and autoimmune diseases. Its geographical segments are the United Kingdom and the United States, of which the majority of its revenue comes from the United States.

Ticker

$IMCR
Trading on

Industry

Biotechnology

Employees

497

Immunocore Metrics

BasicAdvanced
$1.7B
Market cap
-
P/E ratio
-$0.95
EPS
0.72
Beta
-
Dividend rate
$1.7B
0.72
$76.98
$29.72
252K
3.778
3.624
114.274
127.324
-5.26%
-5.22%
-12.83%
5.679
4.47
4.47
84.683
25.09%
-32.96%
100.70%
-37.93%

What the Analysts think about Immunocore

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Immunocore stock.

Immunocore Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Immunocore Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $IMCR

$

Sign up or log in to buy
Capital at risk
Market closedADR

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Immunocore stock?

Immunocore (IMCR) has a market cap of $1.7B as of November 13, 2024.

What is the P/E ratio for Immunocore stock?

The price to earnings (P/E) ratio for Immunocore (IMCR) stock is 0 as of November 13, 2024.

Does Immunocore stock pay dividends?

No, Immunocore (IMCR) stock does not pay dividends to its shareholders as of November 13, 2024.

When is the next Immunocore dividend payment date?

Immunocore (IMCR) stock does not pay dividends to its shareholders.

What is the beta indicator for Immunocore?

Immunocore (IMCR) has a beta rating of 0.72. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.